Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
AUA Announces Updates to Clinical Guidance for Surgical Management of LUTS Attributed to BPH
LINTHICUM, Md., May 2, 2019 /PRNewswire/ — The American Urological Association (AUA) announced today amendments to its clinical guideline on the Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Hyperplasia, originally published in 2018. The amendment updates contain statements reflecting research published through January 2019, including new clinical guidance on aquablation surgical therapy.
The Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline was amended as follows:
- Updates to Guideline Statements 13, 17, 18, 22 and 23 to include newly published research.
- Statement 14 was amended to highlight that patients should be informed that the evidence of efficacy and retreatment rates of prostatic urethral lift (PUL) are poorly defined. A study of PUL that aimed to treat men with obstruction, including a middle lobe, was reviewed, but ultimately not included in the amendment because it was not a randomized trial.
The following statement was added to the Surgical Therapy section of the Guideline:
- Statement 21: Aquablation may be offered to patients with LUTS attributed to BPH provided prostate volume >30/<80g, however, patients should be informed that long term evidence of efficacy and retreatment rates remains limited.
The full text of the amended clinical guideline on Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia is available online.
Members of the BPH Guideline Panel: Harris E. Foster, MD, Tobias S. Kohler, MD, Lori B. Lerner, MD, J. Kellogg Parsons, MD, Kevin T. McVary, MD.
All AUA clinical practice guidance documents, including guidelines, best practices and white papers, are available online at www.auanet.org/guidelines.
About the American Urological Association: Founded in 1902 and headquartered near Baltimore, Maryland, the American Urological Association is a leading advocate for the specialty of urology, and has more than 22,000 members throughout the world. The AUA is a premier urologic association, providing invaluable support to the urologic community as it pursues its mission of fostering the highest standards of urologic care through education, research and the formulation of health policy.
Contact: Christine Frey, AUA
443-909-0839, cfrey@AUAnet.org
SOURCE American Urological Association